The course of patients with Chagas heart disease during episodes of decompensated heart failure

Abstract Aims This study aimed to analyse the clinical presentation and prognosis of patients with Chagas cardiomyopathy and decompensated heart failure (HF), as compared with other aetiologies. Methods and results A prospective cohort of patients admitted with decompensated HF. We included 767 pati...

Full description

Bibliographic Details
Main Authors: Victor Sarli Issa, Silvia Moreira Ayub‐Ferreira, Matthew Schroyens, Paulo Roberto Chizzola, Paulo Rogerio Soares, Silvia Helena Gelas Lage, Edimar Alcides Bocchi
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.13232
Description
Summary:Abstract Aims This study aimed to analyse the clinical presentation and prognosis of patients with Chagas cardiomyopathy and decompensated heart failure (HF), as compared with other aetiologies. Methods and results A prospective cohort of patients admitted with decompensated HF. We included 767 patients (63.9% male), with median age of 58 years [interquartile range 48.2–66.7 years]. Main aetiologies were non‐Chagas/non‐ischaemic cardiomyopathies in 389 (50.7%) patients, ischaemic disease in 209 (27.2%), and Chagas disease in 169 (22%). Median left ventricular ejection fraction was 26% (interquartile range 22–35%). Patients with Chagas differed from both patients with non‐Chagas/non‐ischaemic and ischaemic cardiomyopathies for a higher proportion of cardiogenic shock at admission (17.8%, 11.6%, and 11%, respectively, P < 0.001) and had lower blood pressure at admission (systolic blood pressure 90 [80–102.5], 100 [85–110], and 100 [88.2–120] mmHg, P < 0.001) and lower heart rate (heart rate 71 [60–80], 87 [70–102], and 79 [64–96.5] b.p.m., P < 0.001). Further, patients with Chagas had higher serum BNP level (1544 [734–3148], 1061 [465–239], and 927 [369–1455] pg/mL, P < 0.001), higher serum bilirubin (1.4 [0.922.44], 1.2 [0.77–2.19], and 0.84 [0.49–1.45] mg/dL, P < 0.001), larger left ventricular diameter (68 [63–73], 67 [58–74], and 62 [56.8–68.3] mm, respectively, P < 0.001), lower left ventricular ejection fraction (25 [21–30]%, 26 [22–35]%, and 30 [25–38]%, P < 0.001), and a higher proportion of patients with right ventricular function (48.8%, 40.7%, and 25.9%, P < 0.001). Patients with Chagas disease were more likely to receive inotropes than patients with non‐Chagas/non‐ischaemic and ischaemic cardiomyopathies (77.5%, 67.5%, and 62.5%, respectively, P = 0.007) and also to receive intra‐aortic balloon pumping (30.8%, 16.2%, and 10.5%, P < 0.001). Overall, the rates of death or urgent transplant were higher among patients with Chagas than in other aetiologies, a difference that was driven mostly due to increased rate of heart transplant during hospital admission (20.2%, 10.3%, and 8.1%). The prognosis of patients at 180 days after hospital admission was worse for patients with Chagas disease as compared with other aetiologies. In patients with Chagas, age [odds ratio (OR) = 0.934, confidence interval (CI)95% 0.901–0.982, P = 0.005], right ventricular dysfunction by echocardiography (OR = 2.68, CI95% 1.055–6.81, P = 0.016), and urea (OR = 1.009, CI95% 1.001–1.018, P = 0.038) were significantly associated with prognosis. Conclusions Patients with Chagas cardiomyopathy and decompensated HF have a distinct clinical presentation and worse prognosis compared with other aetiologies.
ISSN:2055-5822